Pay in 4 interest-free payments of $38.75 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
reaching a maximum increase of 1
with a 96% reduction in mean tumor volume at the final measurement compared to the start of treatment
and 25 mg/kg prolongs median survival to 19
2 μM and has no significant effect on both the inward rectifier potassium current and the L-type calcium current
Fujimori A
AEE788 60258 reaching a maximum increase ofAEE 788 is an orally bioavailable multiple receptor tyrosine kinase inhibitor. AEE788 inhibits phosphorylation of the tyrosine kinases of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), and vascular endothelial growth factor receptor 2 (VEGF2), resulting in receptor inhibition, the inhibition of cellular proliferation, and induction of tumor cell and tumor associated endothelial cell apoptosis. Check for
US$ 43.80
US$ 11809.39
US$ 108.81
US$ 59.80
US$ 33.00
US$ 36.40
US$ 59.80
US$ 24.80
US$ 108.81
US$ 62.80
US$ 59.80
US$ 20.80